|
FAM190A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.64313007644523E-12 |
| Normal-vs-Stage2 |
1.62925228863742E-12 |
| Normal-vs-Stage3 |
2.44249065417534E-15 |
| Normal-vs-Stage4 |
4.1133763062362E-13 |
| Stage1-vs-Stage2 |
4.451000E-01 |
| Stage1-vs-Stage3 |
1.842820E-01 |
| Stage1-vs-Stage4 |
7.827600E-01 |
| Stage2-vs-Stage3 |
7.024200E-01 |
| Stage2-vs-Stage4 |
7.606800E-01 |
| Stage3-vs-Stage4 |
5.221800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
<1E-12 |
| Normal-vs-Asian |
1.243010E-04 |
| Caucasian-vs-AfricanAmerican |
8.641800E-01 |
| Caucasian-vs-Asian |
6.032000E-01 |
| AfricanAmerican-vs-Asian |
6.077800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
3.120400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.62536650805123E-12 |
| Normal-vs-Extreme_Weight |
1.62969637784727E-12 |
| Normal-vs-Obese |
<1E-12 |
| Normal-vs-Extreme_Obese |
1.18759999945262E-07 |
| Normal_Weight-vs-Extreme_Weight |
3.265800E-01 |
| Normal_Weight-vs-Obese |
7.955200E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.154400E-01 |
| Extreme_Weight-vs-Obese |
3.727800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.540200E-01 |
| Obese-vs-Extreme_Obese |
6.671200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.64801505775358E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
9.99200722162641E-16 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.194000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.740000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.087250E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.967800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.385570E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.038300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.64113167500091E-12 |
| Normal-VS-Type2 PRCC |
<1E-12 |
| Normal-VS-KIRP CIMP |
1.14719345134517E-12 |
| Normal-VS-Unclassified PRCC |
5.44009282066327E-15 |
| Type1 PRCC-VS-Type2 PRCC |
8.468200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.305400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.439800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.972400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.724600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.765200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62503344114384E-12 |
| Normal-vs-N1 |
1.6278089987054E-12 |
| Normal-vs-N2 |
7.95869999999921E-05 |
| N0-vs-N1 |
5.762800E-01 |
| N0-vs-N2 |
7.959400E-01 |
| N1-vs-N2 |
9.980000E-01 |
|
|
